Who to call at InMed Pharmaceuticals Inc., and when
Fundz watches for the moments InMed Pharmaceuticals Inc. starts buying, and tells you who to reach.
- An alert the day InMed Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at InMed Pharmaceuticals Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at InMed Pharmaceuticals Inc.. With Fundz connected, it knows.
InMed Pharmaceuticals Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.inmedpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
InMed Pharmaceuticals appointed John Bathery as a director on October 14, 2025, expanding the Board to six members, and director Bryan Baldasare will not stand for re-election at the 2025 Annual General Meeting. The changes are a routine board refresh with no disclosed disagreements.
Key Takeaways
John Bathery joined the Board on October 14, 2025, and the Board was concurrently expanded from five to six members.
Bathery's committee assignments have not been determined, and his term runs until immediately before the 2025 Annual General Meeting.
3 more takeaways
Filing Overview
What This Means
InMed Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.